According to Nova one advisor, the global Cell Culture Media, Sera, and Reagents market size is expected to hit around USD 18.20 billion by 2030 from valued at USD 8.1 billion in 2021 and growing at a CAGR of 10.15% from 2022 to 2030.
A typical cell culture medium is composed of a complement of amino acids, vitamins, inorganic salts, glucose, and serum as a source of growth factors, hormones, and attachment factors
Cell culture reagents include cell culture media, media supplements, and sterile reagents. Common cell culture reagents are antibiotics and amino acid supplements.
The serum is a complex mix of albumins, growth factors, and growth inhibitors and is probably one of the most important components of a cell culture medium. Fetal bovine serum (FBS) is the most commonly used serum. The serum regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.
Report Scope of the Cell Culture Media, Sera, and Reagents Market
Rise in Demand for Biopharmaceuticals to Drive Global Market
Cell culture products increase productivity by lowering manufacturing costs. Cell culture is a process of removing cells from an animal or plant source, and use these cells for creating biosimilar or biologic therapeutics. Due to the increasing demand for biosimilar and biologics products for the treatment of cancer and various other chronic and cardiovascular diseases, cell culture method is found to be effective and efficient in the biopharmaceutical sector.
Biosimilar products have gained tremendous popularity in North America and Europe. There is an increasing demand for cost-effective cell culture products and artificial organs across the globe. Antibiotics and amino acid supplements are the most common cell culture reagents used in developing nations. Moreover, increasing applications of Fetal bovine serum (FBS) in regulating cell membrane permeability is fueling the global market growth.
Stem Cell Research and Surge in Demand for Contract Manufacturing
Stem cell research is one of the key drivers for the global cell culture media, sera, and reagents market. Rise in awareness about the stem cell therapy for the treatment of various diseases is fueling market growth. Hence, there is an increasing demand for contract manufacturing. Rapid expansion of pharmaceutical companies, superior drug development & discovery procedures, increase in the number of clinical research institutes across the globe are some of the factors contributing to the global cell culture media, sera, and reagents market growth. However, high costs, along with the scarcity of suitable infrastructure for R&D is expected to hamper the market growth during the forecast period.
Lucrative Growth Opportunities in North America for Cell Culture Media, Sera, and Reagents Market Players
North America is expected to account for a major share of the global cell culture media, sera, and reagents market during the forecast period. The lucrative presence of market players operating in the North America cell culture media, sera, and reagents market is a major factor responsible for the market growth in the region. The North America cell culture media, sera, and reagents market is also driven by the strong support from governments, increasing investments in cell-based research & development, and regulatory approvals for cell culture-based vaccines.
The increase in demand for animal component-free media and automated cell culture systems is expected to create growth opportunities in North America for market players. In addition, the rising prevalence of diseases such as cancer in the region is contributing to the expansion of the market.
Countries in Asia Pacific such as China and India are the fastest growing markets for cell culture media, sera, and reagents in the region. Rapid urbanization and increasing investments in research activities are key factors contributing to the market growth in Asia Pacific. Companies operating in the regional market are expected to witness potential growth opportunities. Technological advancements in healthcare, high biopharmaceutical R&D expenditure, and greater adoption of advanced technologies are also fueling the growth of the market in the region.
Impact of COVID-19 on Cell Culture Media, Sera, and Reagents Market
The global coronavirus pandemic has created opportunities for manufacturers operating in the global cell culture media, sera, and reagents market. This is due to the increasing demand for vaccines across the globe. The global cell culture media, sera, and reagents market is expected to be driven by rising research-based activities, along with clinical trials of vaccines. The global cell culture media, sera, and reagents market is also fueled by surge in demand for biopharmaceuticals, increase in product development by key market contributors, and development of novel vaccines.
There is an increasing demand for cost-effective, reliable, low-risk, and highly efficient cell culture products such as bioreactors, media, reagents, and sera for the creation of high-yield cell lines. In order to fulfill this demand, many cell culture manufacturers are focusing on increasing the production of innovative products.
Rise in Demand for Biopharmaceuticals and Artificial Organs: Major Driver
- The global biological drugs market, which is currently valued at over US$ 285.5 Bn, comprises hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, etc. The limited applicability of conventional pharmaceuticals in curing diseased or injured tissues has led to an increase in demand for biologics.
- The specificity of biopharmaceuticals has opened new avenues in health care such as personalized medicine, wherein various diseases or conditions can be treated using specific biomolecules depending upon the patient’s physiological, biological, and genetic makeup
- Limited competition from generics (called biosimilars) is also driving the market, as these drugs are developed using unique processes involving growth of live cell cultures under controlled environmental conditions
Cell Culture Media, Sera, and Reagents Market: Segmentation
- The global cell culture media, sera, and reagents market has been segmented based on product, end-user, and region
- In terms of product, the global market has been classified into media, sera, and reagents. The media segment has been segregated into chemically defined, classical media, lysogeny broth, protein free, serum-free, and specialty media. The sera segment has been categorized into fetal bovine, newborn calf, and others. The reagents segment has been divided into albumin, amino acids, attached factors, and growth factors & cytokines.
- Based on end-user, the global cell culture media, sera, and reagents market has been categorized into biotechnology & pharmaceutical companies, academic & research institutes, and others
North America to Dominate Cell Culture Media, Sera, and Reagents Market
- In terms of region, the global cell culture media, sera, and reagents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is projected to dominate the global market from 2021 to 2030. The U.S. is the largest market for biopharmaceuticals, accounting for around a third of the global market, and is the world leader in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. companies conduct over half the world's R&D. This drives the demand for cell culture media, sera, and reagents in North America.
- Increase in demand for animal component-free media and automated cell culture systems are the key factors contributing to the growth of cell culture in North America. Additionally, recent reforms in the cell culture industry in the region regarding the use of human-derived media agents in cell culture are likely to fuel the growth of the market.
Some of the prominent players in the Cell Culture Media, Sera, and Reagents Market include:
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Cytiva (Danaher Corporation)
- Becton
- Dickinson and Company
- Corning Incorporated
- HiMedia Laboratories
- FUJIFILM Irvine Scientific, Inc.
- InvivoGen
- SeraCare (LGC Clinical Diagnostics, Inc.)
- Lonza
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Cell Culture Media, Sera, and Reagents market
- Product
- Media
- Chemically-defined
- Classical Media
- Lysogeny Broth
- Protein Free
- Serum-Free
- Specialty Media
- Sera
- Fetal Bovine
- Newborn Calf
- Others
- Reagents
- Albumin
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Serum Albumin
- Fetal Bovine
- Newborn Calf
- Others
- Amino Acids
- Attached Factors
- Growth Factors & Cytokines
- Transforming Growth Factor ß1
- Epidermal Growth Factor
- Interleukins & Interferons
- Others
- End-user
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Others
By Geography
North America
Europe
- Germany
- France
- United Kingdom
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Cell Culture Media, Sera, and Reagents industry analysis from 2022 to 2030 to identify the prevailing Cell Culture Media, Sera, and Reagents industry opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the global Cell Culture Media, Sera, and Reagents industry segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global Cell Culture Media, Sera, and Reagents industry trends, key players, market segments, application areas, and market growth strategies.
Request Customization
Get a Sample
Get a Sample
Request Customization